AYTU vs ECL · rev $66.4M vs P/E 35, rev $4.01B
Aytu BioScience Inc (AYTU) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was up 1.8% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AYTU currently screens at market cap $24.1M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AYTU and ECL stock pages for the full models.
Not investment advice.